Previous Section Index Home Page

14 Mar 2007 : Column 416W—continued


14 Mar 2007 : Column 417W

14 Mar 2007 : Column 418W

Table 2c: Projected population and proportions of population in 2029 by strategic health authority( 1) for specific age groups
2029
Total population Over state pension age 65+ 75+ 85+
Thousand Thousand Percentage Thousand Percentage Thousand Percentage Thousand Percentage

North East SHA

2,638

725

27.5

632

24.0

315

11.9

93

3.5

North West SHA

7,331

1,881

25.7

1,632

22.3

822

11.2

246

3.4

Yorkshire and the Humber SHA

5,738

1,450

25.3

1,261

22.0

638

11.1

194

3.4

East Midlands SHA

4,874

1,347

27.6

1,174

24.1

605

12.4

185

3.8

West Midlands SHA

5,749

1 ,478

25.7

1,288

22.4

670

11.7

212

3.7

East SHA

6,308

1,732

27.5

1,517

24.0

799

12.7

253

4.0

London SHA

8,807

1,386

15.7

1,167

13.2

549

6.2

171

1.9

South East Coast SHA

4,814

1,315

27.3

1,149

23.9

605

12.6

196

4.1

South Central SHA

4,336

1,073

24.8

939

21.6

494

11.4

160

3.7

South West SHA

5,862

1,766

30.1

1,548

26.4

824

14.0

264

4.5

(1 )Strategic health authorities based on 2006 boundaries.
Source:
Office for National Statistics

Revenue and Customs: Standards

Mr. Francois: To ask the Chancellor of the Exchequer what factors led to HM Revenue and Customs being awarded a Red RAG score by the Office of Government Commerce in 2006. [126854]

Mr. Timms: The OGC have not published any RAG scores for HM Revenue and Customs in 2006.

Small Businesses: EC Countries

Mr. Francois: To ask the Chancellor of the Exchequer how many small and medium-sized UK enterprises have used the STIMUTRAN-SME project. [126907]

Mr. Woolas: I have been asked to reply.

The STIMUTRAN-SME project aims to boost innovation and knowledge transfer between small and medium-sized enterprises (SMEs) of North West Europe through “Transnational Matching Centres” (TMCs). These will help SMEs develop transnational business activities and help them find compatible business partners in the North West Europe region. Small and medium-sized enterprises from the UK have not yet had the opportunity to benefit from the STIMUTRAN-SME project as the TMCs have not yet commenced operations, but will do so shortly.

Mr. Francois: To ask the Chancellor of the Exchequer what the cost has been to the public purse of the STIMUTRAN-SME project; and how much has been provided by the European Commission to the project. [126908]

Mr. Woolas: I have been asked to reply.

The total budget for STIMUTRAN-SME, a North West Europe INTERREG project, is £171,227.47, which is made up of European Regional Development Funding (ERDF) of £373,069.18 and £404,158.28 match funding provided by the 10 project partners themselves.

The four UK partners (Southern Area Euro Info Centre; Highland Opportunity Limited; Birmingham Chamber of Commerce and Industry; Business Link Kent) between them have a total budget for the life span of the project (2006-08) of £235,340.92. 48 per cent. of this is funded by ERDF (£112,963.32). The remainder, £122,377.60, has been provided by the four partners themselves. It is not possible to determine precisely how much of the match funding provided by partners may have originated from the public purse.

Statistics: Constituencies

Mr. Slaughter: To ask the Chancellor of the Exchequer whether his Department has issued guidance to other Government departments on the production of statistics for new parliamentary constituencies. [126442]

John Healey: The information requested falls within the responsibility of the National Statistician, who has been asked to reply.

Letter from Karen Dunnell, dated 14 March 2007:


14 Mar 2007 : Column 419W

Mr. Slaughter: To ask the Chancellor of the Exchequer if he will provide the key statistics for the proposed parliamentary constituencies of (a) Ealing Central and Acton and (b) Hammersmith Borough from the 2001 census data. [126443]

John Healey: The information requested falls within the responsibility of the National Statistician, who has been asked to reply.

Letter from Karen Dunnell, dated 14 March 2007:

Tax Evasion

Kelvin Hopkins: To ask the Chancellor of the Exchequer what his latest estimate is of the differences between the tax and duties which should have been paid and those which were paid in 2005-06. [126236]

John Healey: There are no reliable estimates for the difference between the total tax and duties that should have been paid and the amount actually paid in 2005-06.

However, estimates of revenue losses in indirect taxes are available and are reported in “Measuring Indirect Tax Losses—2006”, which is published alongside the PBR and can be found in the House of Commons Library.

Taxation: Aviation

Natascha Engel: To ask the Chancellor of the Exchequer if he will assess the merits of exempting charities from the requirement to pay air passenger duty. [126544]


14 Mar 2007 : Column 420W

John Healey: Air passenger duty increased on 1 February in recognition of the environmental costs of air travel. This will deliver carbon savings of around 0.3MtC a year by 2010-11, or around 0.75MtC per year by 2010-11 when the effect of non-carbon dioxide emissions at high altitude is taken into account.

The Government are committed to supporting charities and the third sector through a range of tax reliefs and other measures. In 2005-06, tax reliefs for the charitable sector were worth in excess of £2.5 billion.

Given the level of support already extended to charities through the tax system and the administrative structure of air passenger duty the Government does not currently believe that an air passenger duty exemption would be appropriate.

The Chancellor keeps all taxation policy under review, and considers all relevant economic, social and environmental factors in deciding future policy.

Tobacco: Smuggling

Kelvin Hopkins: To ask the Chancellor of the Exchequer what his estimate is of lost revenue to his Department due to tobacco smuggling from other EU states. [126240]

John Healey: It is not possible to estimate the level of tobacco smuggling solely from other EU states. Estimates are only produced on the revenue loss from smuggling originating from within and outside of the EU combined.

The estimated revenue loss to the Exchequer (duty plus VAT) on cigarettes and hand rolling tobacco due to fraud, smuggling and counterfeiting for 2000-01 to 2004-05 is reported in “Measuring Indirect Tax Losses—2006” published by HMRC in December 2006 and is available in the House of Commons Library.

Health

Breast Feeding

Andrew George: To ask the Secretary of State for Health what estimate she has made of the number of women who breastfed their babies for the first six months in each year since 1995. [126156]

Mr. Ivan Lewis: The national infant feeding survey conducted every five years provides information on the percentage of women breastfeeding their babies for the first six months. Both the 1995 and 2000 survey showed that 22 per cent. of the women breastfed their babies for the first six months in England and Wales as compared to 21 per cent. in the United Kingdom. Figures for the prevalence of breastfeeding each year are not available.

The results of the national infant feeding survey 2005 are expected to be published in summer 2007.

Cancer: Drugs

Mr. Baron: To ask the Secretary of State for Health if she will ask the National Institute for Health and Clinical Excellence to undertake an appraisal of the
14 Mar 2007 : Column 421W
kidney cancer drugs (a) Sutent and (b) Nexavar; what responsibilities primary care trusts have to make these drugs available to patients; and if she will make a statement. [125213]

Caroline Flint [holding answer 5 March 2007]: The Department has asked the National Institute for Health and Clinical Excellence (NICE) to consult on the remit and scope for an appraisal of Nexavar for the treatment of renal cell carcinoma. A final decision on referral of this topic to NICE will be made in April 2007. The Department is currently considering referring Sutent to NICE for appraisal.

In December 2006, the Department issued good practice guidance to the national health service on the managed introduction of new technologies. The guidance updates and clarifies the messages in an earlier Health Service Circular 1999/176 and makes clear to NHS organisations that they should not refuse to fund a treatment simply because NICE guidance does not yet exist. Until NICE has issued final
14 Mar 2007 : Column 422W
guidance on a treatment, NHS bodies should continue with local arrangements for the managed introduction of new technologies, taking account of the available evidence.


Next Section Index Home Page